A Multicenter, Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting from Combined Use of Nestorone Gel (0, 8 or 12 mg NES) and Testosterone Gel (10g) Compared with Testosterone Gel in Normal Men (Protocol CCN007) (Short Title: NES-2).
Phase of Trial: Phase I
Latest Information Update: 30 May 2018
At a glance
- Drugs Elcometrine (Primary) ; Testosterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms NES-2
- 26 Jun 2012 Status changed from active, no longer recruiting to completed.
- 13 Feb 2011 Actual Initiation Date (1 May 2009 ) added ss reported by ClinicalTrials.gov.
- 13 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History